ASMB

Companies
NASDAQ
Assembly Biosciences Inc.
Health Care
Price Chart
Overview

About ASMB

Assembly Biosciences Inc is a clinical-stage biotechnology company. It is advancing two innovative platform programs, a novel class of oral therapeutics for the treatment of hepatitis B virus (HBV) infection and novel class of oral synthetic live biotherapeutics, which are designed to restore health to a dysbiotic microbiome. The company's HBV-cure program is aimed at increasing the current low cure rate for patients with HBV and is pursuing multiple drug candidates that inhibit multiple steps of the HBV lifecycle. Assembly has discovered several novel core protein Allosteric Modulators, which are small molecules that directly target and allosterically modulate the HBV core protein. The majority of the revenue is generated from the HBV cure program.

Market Cap
$78.7M
Volume
287.1K
Avg. Volume
422.2K
P/E Ratio
-1.9337176
Dividend Yield
0.00%
Employees
87.0

Company Information

Exchange
NASDAQ
Sector
Health Care
Industry
Biotechnology
Risk & Correlation Analysis
Market Correlation
1.33
High Correlation
Volatility
High (0.68)
Relative to market

Macro Factor Sensitivities

Interest Rates
Low Sensitivity
Inflation
Low Sensitivity
GDP Growth
High Sensitivity
Liquidity
High Sensitivity
Commodity Prices
Medium Sensitivity
Credit Quality
High Sensitivity
Portfolio Impact
Forecasts & Predictions

Premium Forecasts

Get AI-powered price predictions, technical analysis, and market forecasts for ASMB.

1-Month Target
$XXX.XX
+X.X% Potential
3-Month Target
$XXX.XX
+X.X% Potential
12-Month Target
$XXX.XX
+X.X% Potential

Technical Analysis

Based on technical indicators and chart patterns, ASMB shows...

AI Sentiment Analysis

Market sentiment analysis indicates...

Key Statistics
Market Cap$78.7M
Volume287.1K
P/E Ratio-1.93
Dividend Yield0.00%
Important Dates
Next Dividend
Next Earnings
May 9, 2025

PortfolioPilot Analysis

Get AI-powered insights on how ASMB fits into your investment strategy and portfolio diversification.

Pricing info last updated June 18, 2025 (after market close)Other info last updated April 2, 2025